Dayle Hogg
InvestorManaging Director at International Finance Corporation · Operating Executive at Abingworth
London, England, United Kingdom
Find your path to Dayle
Sign up to see every warm intro you have to Dayle
- Paths you didn't know you had: your email and LinkedIn already hold routes to Dayle. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Dayle Hogg joined Abingworth in March 2023 to support the operational capabilities of portfolio companies. He was previously COO of GammaDelta Therapeutics until its 2022 acquisition by Takeda, cofounder of Adaptate Biotherapeutics, COO of Kesios Therapeutics, and an investment manager at Touchstone Innovations, and he cofounded Lectus Therapeutics. He holds a degree in Pharmacology from the University of Leeds and a PhD in Pharmacology from the University of Oxford.
Invests in
Biotech
Investments
Led
Enterprise TherapeuticsStorm Therapeutics
Per the firm's website.
Colleagues at International Finance Corporation
Frequently asked questions
- Who is Dayle Hogg?
- Dayle Hogg joined Abingworth in March 2023 to support the operational capabilities of portfolio companies. He was previously COO of GammaDelta Therapeutics until its 2022 acquisition by Takeda, cofounder of Adaptate Biotherapeutics, COO of Kesios Therapeutics, and an investment manager at Touchstone Innovations, and he cofounded Lectus Therapeutics. He holds a degree in Pharmacology from the University of Leeds and a PhD in Pharmacology from the University of Oxford.
- Where does Dayle Hogg work?
- Dayle Hogg is Managing Director at International Finance Corporation and Operating Executive at Abingworth.
- What does Dayle Hogg invest in?
- Dayle Hogg invests in Biotech.
- What companies has Dayle Hogg invested in?
- Investments tracked here include Enterprise Therapeutics, Storm Therapeutics.
- Does Dayle Hogg lead rounds?
- Yes — Dayle Hogg has led 2 tracked investments.
About this profile. Compiled from public sources — International Finance Corporation's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights







